Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty

Abstract Background The onset of deep vein thrombosis (DVT) in patients after total hip arthroplasty (THA) may expand or enlarge and subsequently lead to significant mortality. The objective of this study was to investigate potential risk factors for DVT in patients after THA. Methods Eligible patie...

Full description

Bibliographic Details
Main Authors: Ju Tang, Wei Zhu, Xiaoliang Mei, Zhenxiang Zhang
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13018-018-0716-2
_version_ 1798040855098949632
author Ju Tang
Wei Zhu
Xiaoliang Mei
Zhenxiang Zhang
author_facet Ju Tang
Wei Zhu
Xiaoliang Mei
Zhenxiang Zhang
author_sort Ju Tang
collection DOAJ
description Abstract Background The onset of deep vein thrombosis (DVT) in patients after total hip arthroplasty (THA) may expand or enlarge and subsequently lead to significant mortality. The objective of this study was to investigate potential risk factors for DVT in patients after THA. Methods Eligible patients with hip joint diseases who were scheduled for unilateral primary THA at our hospital were prospectively included into this study. The demographic and clinical features, preoperative plasma biomarkers were detailed, recorded, and compared. The multiple logistic regression analysis was used to evaluate potential risk factors for DVT. Results A total of 214 subjects were enrolled into our study cohort for the final analysis, and 23 of them have suffered DVT with an incidence of 9.5%. The performance of logistic regression analysis showed that preoperative expression of plasminogen activator inhibitor-1 (PAI-1) was an independent risk factor for the onset of DVT in patients after THA (OR 1.18, 95% CI 1.04–1.29; p = 0.011). Conclusions Our study indicated preoperative plasma PAI-1 expression as an independent risk factor for DVT in patients who underwent THA.
first_indexed 2024-04-11T22:13:26Z
format Article
id doaj.art-2c9550d986294761a2b7510d627bad1c
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-11T22:13:26Z
publishDate 2018-01-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-2c9550d986294761a2b7510d627bad1c2022-12-22T04:00:30ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2018-01-011311510.1186/s13018-018-0716-2Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplastyJu Tang0Wei Zhu1Xiaoliang Mei2Zhenxiang Zhang3Department of Joint Surgery, Taizhou People’s Hospital, Medical School of Nantong UniversityDepartment of Joint Surgery, Taizhou People’s Hospital, Medical School of Nantong UniversityDepartment of Joint Surgery, Taizhou People’s Hospital, Medical School of Nantong UniversityDepartment of Joint Surgery, Taizhou People’s Hospital, Medical School of Nantong UniversityAbstract Background The onset of deep vein thrombosis (DVT) in patients after total hip arthroplasty (THA) may expand or enlarge and subsequently lead to significant mortality. The objective of this study was to investigate potential risk factors for DVT in patients after THA. Methods Eligible patients with hip joint diseases who were scheduled for unilateral primary THA at our hospital were prospectively included into this study. The demographic and clinical features, preoperative plasma biomarkers were detailed, recorded, and compared. The multiple logistic regression analysis was used to evaluate potential risk factors for DVT. Results A total of 214 subjects were enrolled into our study cohort for the final analysis, and 23 of them have suffered DVT with an incidence of 9.5%. The performance of logistic regression analysis showed that preoperative expression of plasminogen activator inhibitor-1 (PAI-1) was an independent risk factor for the onset of DVT in patients after THA (OR 1.18, 95% CI 1.04–1.29; p = 0.011). Conclusions Our study indicated preoperative plasma PAI-1 expression as an independent risk factor for DVT in patients who underwent THA.http://link.springer.com/article/10.1186/s13018-018-0716-2Total hip arthroplastyDeep vein thrombosisPlasminogen activator inhibitor-1Risk factor
spellingShingle Ju Tang
Wei Zhu
Xiaoliang Mei
Zhenxiang Zhang
Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
Journal of Orthopaedic Surgery and Research
Total hip arthroplasty
Deep vein thrombosis
Plasminogen activator inhibitor-1
Risk factor
title Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
title_full Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
title_fullStr Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
title_full_unstemmed Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
title_short Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
title_sort plasminogen activator inhibitor 1 a risk factor for deep vein thrombosis after total hip arthroplasty
topic Total hip arthroplasty
Deep vein thrombosis
Plasminogen activator inhibitor-1
Risk factor
url http://link.springer.com/article/10.1186/s13018-018-0716-2
work_keys_str_mv AT jutang plasminogenactivatorinhibitor1ariskfactorfordeepveinthrombosisaftertotalhiparthroplasty
AT weizhu plasminogenactivatorinhibitor1ariskfactorfordeepveinthrombosisaftertotalhiparthroplasty
AT xiaoliangmei plasminogenactivatorinhibitor1ariskfactorfordeepveinthrombosisaftertotalhiparthroplasty
AT zhenxiangzhang plasminogenactivatorinhibitor1ariskfactorfordeepveinthrombosisaftertotalhiparthroplasty